CompaniesWako Diagnostics

Wako Diagnostics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

620

By Phase

PHASE1/PHASE2: 1

By Status

COMPLETED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT01360255
NCT01361061
NCT06892951
Hover over trial bars to see details

Recent Trials

NCT06892951Collaborator
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia
PHASE1/PHASE2Not yet recruiting
100 participants
Started: Jun 30, 2025 · Completed: Dec 31, 2028
NCT01361061Collaborator
AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver
N/ACompleted
450 participants
Started: Jun 30, 2010 · Completed: Nov 30, 2015
NCT01360255Collaborator
AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)
N/ACompleted
70 participants
Started: May 31, 2010 · Completed: Nov 15, 2015
Related Companies
Fujifilm
acquired